312 related articles for article (PubMed ID: 22038764)
21. Unsolved challenges in pediatric whole-exome sequencing: A literature analysis.
Bertier G; Sénécal K; Borry P; Vears DF
Crit Rev Clin Lab Sci; 2017 Mar; 54(2):134-142. PubMed ID: 28132577
[TBL] [Abstract][Full Text] [Related]
22. A framework for tiered informed consent for health genomic research in Africa.
Nembaware V; Johnston K; Diallo AA; Kotze MJ; Matimba A; Moodley K; Tangwa GB; Torrorey-Sawe R; Tiffin N
Nat Genet; 2019 Nov; 51(11):1566-1571. PubMed ID: 31659323
[TBL] [Abstract][Full Text] [Related]
23. Minimizing liability risks under the ACMG recommendations for reporting incidental findings in clinical exome and genome sequencing.
Evans BJ
Genet Med; 2013 Dec; 15(12):915-20. PubMed ID: 24030435
[TBL] [Abstract][Full Text] [Related]
24. Research ethics and the challenge of whole-genome sequencing.
McGuire AL; Caulfield T; Cho MK
Nat Rev Genet; 2008 Feb; 9(2):152-6. PubMed ID: 18087293
[TBL] [Abstract][Full Text] [Related]
25. The tension between data sharing and the protection of privacy in genomics research.
Kaye J
Annu Rev Genomics Hum Genet; 2012; 13():415-31. PubMed ID: 22404490
[TBL] [Abstract][Full Text] [Related]
26. Informed consent for whole-genome sequencing studies in the clinical setting. Proposed recommendations on essential content and process.
Ayuso C; Millán JM; Mancheño M; Dal-Ré R
Eur J Hum Genet; 2013 Oct; 21(10):1054-9. PubMed ID: 23321621
[TBL] [Abstract][Full Text] [Related]
27. Reporting results from whole-genome and whole-exome sequencing in clinical practice: a proposal for Canada?
Zawati MH; Parry D; Thorogood A; Nguyen MT; Boycott KM; Rosenblatt D; Knoppers BM
J Med Genet; 2014 Jan; 51(1):68-70. PubMed ID: 24078715
[TBL] [Abstract][Full Text] [Related]
28. Stakeholder views on secondary findings in whole-genome and whole-exome sequencing: a systematic review of quantitative and qualitative studies.
Mackley MP; Fletcher B; Parker M; Watkins H; Ormondroyd E
Genet Med; 2017 Mar; 19(3):283-293. PubMed ID: 27584911
[TBL] [Abstract][Full Text] [Related]
29. Participants' recall and understanding of genomic research and large-scale data sharing.
Robinson JO; Slashinski MJ; Wang T; Hilsenbeck SG; McGuire AL
J Empir Res Hum Res Ethics; 2013 Oct; 8(4):42-52. PubMed ID: 24169421
[TBL] [Abstract][Full Text] [Related]
30. Points to consider for informed consent for genome/exome sequencing.
ACMG Board of Directors
Genet Med; 2013 Sep; 15(9):748-9. PubMed ID: 23970068
[No Abstract] [Full Text] [Related]
31. Broadening research consent in the era of genome-informed medicine.
Kronenthal C; Delaney SK; Christman MF
Genet Med; 2012 Apr; 14(4):432-6. PubMed ID: 22422050
[TBL] [Abstract][Full Text] [Related]
32. Ethical aspects of participation in the database of genotypes and phenotypes of the National Center for Biotechnology Information: the Cancer and Leukemia Group B Experience.
Peppercorn J; Shapira I; Deshields T; Kroetz D; Friedman P; Spears P; Collyar DE; Shulman LN; Dressler L; Bertagnolli MM
Cancer; 2012 Oct; 118(20):5060-8. PubMed ID: 22415847
[TBL] [Abstract][Full Text] [Related]
33. Managing the ethical challenges of next-generation sequencing in genomic medicine.
Clarke AJ
Br Med Bull; 2014 Sep; 111(1):17-30. PubMed ID: 25122627
[TBL] [Abstract][Full Text] [Related]
34. Genomic research and data-mining technology: implications for personal privacy and informed consent.
Tavani HT
Ethics Inf Technol; 2004; 6(1):15-28. PubMed ID: 16969958
[TBL] [Abstract][Full Text] [Related]
35. Attitudes of African Americans toward return of results from exome and whole genome sequencing.
Yu JH; Crouch J; Jamal SM; Tabor HK; Bamshad MJ
Am J Med Genet A; 2013 May; 161A(5):1064-72. PubMed ID: 23610051
[TBL] [Abstract][Full Text] [Related]
36. Consenting for current genetic research: is Canadian practice adequate?
Jaitovich Groisman I; Egalite N; Godard B
BMC Med Ethics; 2014 Nov; 15():80. PubMed ID: 25410958
[TBL] [Abstract][Full Text] [Related]
37. Old Challenges or New Issues? Genetic Health Professionals' Experiences Obtaining Informed Consent in Diagnostic Genomic Sequencing.
Vears DF; Borry P; Savulescu J; Koplin JJ
AJOB Empir Bioeth; 2021; 12(1):12-23. PubMed ID: 33017265
[TBL] [Abstract][Full Text] [Related]
38. Content Analysis of Informed Consent for Whole Genome Sequencing Offered by Direct-to-Consumer Genetic Testing Companies.
Niemiec E; Borry P; Pinxten W; Howard HC
Hum Mutat; 2016 Dec; 37(12):1248-1256. PubMed ID: 27647801
[TBL] [Abstract][Full Text] [Related]
39. Opportunities and challenges for the integration of massively parallel genomic sequencing into clinical practice: lessons from the ClinSeq project.
Biesecker LG
Genet Med; 2012 Apr; 14(4):393-8. PubMed ID: 22344227
[TBL] [Abstract][Full Text] [Related]
40. "We don't know her history, her background": adoptive parents' perspectives on whole genome sequencing results.
Crouch J; Yu JH; Shankar AG; Tabor HK
J Genet Couns; 2015 Feb; 24(1):67-77. PubMed ID: 25011977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
